Molecular Oncology (Nov 2021)

EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression

  • Jinkwon Lee,
  • Kwangho Kim,
  • Tae Young Ryu,
  • Cho‐Rok Jung,
  • Moo‐Seung Lee,
  • Jung Hwa Lim,
  • Kunhyang Park,
  • Dae‐Soo Kim,
  • Mi‐Young Son,
  • Ryuji Hamamoto,
  • Hyun‐Soo Cho

DOI
https://doi.org/10.1002/1878-0261.13050
Journal volume & issue
Vol. 15, no. 11
pp. 2989 – 3002

Abstract

Read online

Dozens of histone methyltransferases have been identified and biochemically characterized, but the pathological roles of their dysfunction in human diseases such as cancer remain largely unclear. Here, we demonstrate the involvement of EHMT1, a histone lysine methyltransferase, in lung cancer. Immunohistochemical analysis indicated that the expression levels of EHMT1 are significantly elevated in human lung carcinomas compared with non‐neoplastic lung tissues. Through gene ontology analysis of RNA‐seq results, we showed that EHMT1 is clearly associated with apoptosis and the cell cycle process. Moreover, FACS analysis and cell growth assays showed that knockdown of EHMT1 induced apoptosis and G1 cell cycle arrest via upregulation of CDKN1A in A549 and H1299 cell lines. Finally, in 3D spheroid culture, compared to control cells, EHMT1 knockdown cells exhibited reduced aggregation of 3D spheroids and clear upregulation of CDKN1A and downregulation of E‐cadherin. Therefore, the results of the present study suggest that EHMT1 plays a critical role in the regulation of cancer cell apoptosis and the cell cycle by modulating CDKN1A expression. Further functional analyses of EHMT1 in the context of human tumorigenesis may aid in the development of novel therapeutic strategies for cancer.

Keywords